Cargando…
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Neuromyelitis optica (NMO, Devic’s syndrome), long considered a clinical variant of multiple sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the diagnosis and treatment of NMO since aquaporin-4 antibodies (AQP4-Ab; also termed NMO-IgG) were first described in...
Autores principales: | Trebst, Corinna, Jarius, Sven, Berthele, Achim, Paul, Friedemann, Schippling, Sven, Wildemann, Brigitte, Borisow, Nadja, Kleiter, Ingo, Aktas, Orhan, Kümpfel, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895189/ https://www.ncbi.nlm.nih.gov/pubmed/24272588 http://dx.doi.org/10.1007/s00415-013-7169-7 |
Ejemplares similares
-
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
por: Jarius, Sven, et al.
Publicado: (2023) -
The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013) -
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75
por: Krumbholz, Markus, et al.
Publicado: (2015) -
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
por: Stellmann, Jan-Patrick, et al.
Publicado: (2017) -
Olfactory Dysfunction in Patients with Neuromyelitis Optica
por: Schmidt, Felix, et al.
Publicado: (2013)